1. [Mechanism of Luoshi Neiyi Formula in treatment of SF-1 on endometriosis by improving hypoxia].
- Author
-
Wu LZ, Chen XX, Sun BW, Pei FL, Lan DT, Kuang ZJ, Zhang SY, and Zeng C
- Subjects
- Female, Animals, Humans, Rats, Hypoxia drug therapy, Hypoxia genetics, Hypoxia metabolism, Cell Proliferation drug effects, Endometrium drug effects, Endometrium metabolism, Adult, Stromal Cells drug effects, Stromal Cells metabolism, Endometriosis drug therapy, Endometriosis genetics, Endometriosis metabolism, Drugs, Chinese Herbal pharmacology, Drugs, Chinese Herbal administration & dosage, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Rats, Sprague-Dawley, Steroidogenic Factor 1 genetics, Steroidogenic Factor 1 metabolism
- Abstract
This study investigated the effect of Luoshi Neiyi Formula(LSNYF) on hypoxia-inducible factor-1α(HIF-1α) and steroidogenic factor 1(SF-1) in endometriosis(EMs), aiming to explore the mechanism of Luoshi Neiyi Formula in treating EMs. Immunohistochemistry and quantitative real-time PCR(qPCR) were employed to determine the expression of HIF-1α and SF-1 in the endometriotic tissue. Human primary endometrial stromal cells(ESCs) were extracted and identified, in which the expression levels of HIF-1α and SF-1 were measured by immunofluorescence and qPCR. Cobalt chloride(CoCl_2) was used to simulate a low-oxygen environment in vitro, and the lentivirus with down-regulated expression of HIF-1α was constructed. The expression of HIF-1α or SF-1 was then determined by qPCR or Western blot. The effects of Luoshi Neiyi Formula-containing serum on the proliferation, migration, estradiol(E_2), HIF-1α, and SF-1 of ESCs in the low-oxygen environment were observed. Finally, the rat model of EMs with the syndrome of Qi stagnation and blood stasis was established by multi-factor intervention combined with autologous endometrium transplantation, and the effect of Luoshi Neiyi Formula on HIF-1α and SF-1 in the endometriotic tissue were studied. Compared with the normal endo-metrial tissue and ESCs, the endometriotic tissue and ectopic ESCs presented up-regulated mRNA and protein levels of HIF-1α and SF-1. Compared with the control group, treating eutopic ESCs with 50 μmol·L~(-1) CoCl_2 for 24 h promoted cell proliferation and up-regulated the mRNA level of HIF-1α and protein level of SF-1, while knocking down HIF-1α down-regulated the expression of SF-1 and E_2. Compared with the model group, the Luoshi Neiyi Formula-containing serum inhibited the proliferation and migration of ESCs and down-regulated the expression of E_2, HIF-1α, and SF-1. Similarly, the treatment with Luoshi Neiyi Formula attenuated the pathological injury of the endometriotic tissue and down-regulated the mRNA and protein levels of HIF-1α and SF-1 in the rat model of EMs. In summary, LSNYF may treat EMs by alleviating hypoxia and inhibiting the HIF-1α/SF-1 axis.
- Published
- 2024
- Full Text
- View/download PDF